Skip to Content

QHSLab Inc Class A USAQ

Morningstar Rating
$0.06 −0.04 (39.60%)
View Full Chart
Unlock our analysis with Morningstar Investor

About Quantitative Ratings

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.

Price vs Fair Value

USAQ is trading at a 47% discount.
Price
$0.06
Fair Value
$5.17
Uncertainty
Extreme
1-Star Price
$8.96
5-Star Price
$3.22
Economic Moat
Clkg
Capital Allocation
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if USAQ is a good fit for your portfolio.

News

Trading Information

Previous Close Price
$0.10
Day Range
$0.060.06
52-Week Range
$0.020.25
Bid/Ask
$0.06 / $0.11
Market Cap
$623,145.99
Volume/Avg
113 / 35,304

Key Statistics

Price/Earnings (Normalized)
Price/Sales
0.41
Dividend Yield (Trailing)
Dividend Yield (Forward)
Total Yield

Company Profile

QHSLab Inc is a medical device company providing digital healthcare solutions and point-of-care-diagnostic tests to primary care physicians. The company is a medical device technology and software as a service (SaaS) company focused on enabling primary care physicians (PCPs) to increase their revenues by providing them with relevant, value-based tools to evaluate and treat chronic disease as well as provide preventive care through reimbursable procedures.
Sector
Healthcare
Industry
Medical Devices
Stock Style Box
Total Number of Employees
4

Valuation

Metric
USAQ
Price/Earnings (Normalized)
Price/Book Value
Price/Sales
0.41
Price/Cash Flow
Price/Earnings
USAQ

Financial Strength

Metric
USAQ
Quick Ratio
0.06
Current Ratio
0.08
Interest Coverage
−1.03
Quick Ratio
USAQ

Profitability

Metric
USAQ
Return on Assets (Normalized)
−25.50%
Return on Equity (Normalized)
Return on Invested Capital (Normalized)
−15.37%
Return on Assets
USAQ
See how this stock stacks up to its competitors with Morningstar Investor

Medical Devices Industry Comparables

Ticker
Name
Morningstar Rating for Stocks
Capital Allocation
Economic Moat
Market Cap
ABT
Abbott LaboratoriesHgwlhnctPlwznvm$183.8 Bil
SYK
Stryker CorpHscvpmhdgmBktd$127.8 Bil
MDT
Medtronic PLCKyhvsnfKzyhwzg$105.0 Bil
BSX
Boston Scientific CorpWydwbqrHblgkbt$99.9 Bil
EW
Edwards Lifesciences CorpTxxtqfbsLzpdr$52.5 Bil
DXCM
DexCom IncMmcrwmpyqYdpyf$51.9 Bil
ZBH
Zimmer Biomet Holdings IncRlnbkgqqpFdk$24.9 Bil
ALGN
Align Technology IncSqtpvxygVlflbf$22.6 Bil
PHG
Koninklijke Philips NV ADRLtrphlkWrdcy$18.2 Bil
PODD
Insulet CorpJthnmxxwgjXvmzzl$11.6 Bil

Sponsor Center